Pharmicell Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharmicell Company Limited with three other
companies in this sector in South Korea:
Green Cross Cell Corp
sales of 29.61 billion Korean Won [US$25.28 million]
of which 100%
was Biotechnology (BT) Segment),
Eagle Veterinary Technology Co., Ltd
(30.26 billion Korean Won [US$25.84 million]
Cheil Bio Co., Limited.
(27.81 billion Korean Won [US$23.75 million]
During the year ended December of 2018, sales at
Pharmicell Company Limited were 28.35 billion Korean Won (US$24.21 million).
increase of 12.5%
versus 2017, when the company's sales were 25.20 billion Korean Won.
Sales of Bio-Business saw an increase
that was more than double the company's growth rate: sales were up
59.7% in 2018, from
3.19 billion Korean Won to 5.10 billion Korean Won.